51 Biggest Movers From Yesterday

Gainers

• Microbot Medical Inc. MBOT shares climbed 65.1% to close at $8.95 on Monday after the company announced a strategic collaboration with Stryker Corporation to develop the LIBERTY robotic system for neurovascular applications.
• Powerbridge Technologies Co., Ltd. PBTS gained 62.4% to close at $0.93.
• PyroGenesis Canada Inc. PYR climbed 42.3% to settle at $3.60.
• Future FinTech Group Inc. FTFT gained 36.4% to close at $1.50. Future FinTech recently announced plans to build a U.S. crypto mining farm.
• American Virtual Cloud Technologies, Inc. AVCT climbed 35.3% to close at $2.57 after dipping 24% on Thursday.
• CollPlant Biotechnologies Ltd. CLGN jumped 35.3% to settle at $17.89.
• CNFinance Holdings Limited CNF gained 25.4% to close at $3.75.
• Reliance Global Group, Inc. RELI shares rose 22.9% to close at $5.31. Reliance Global Group recently announced pricing of $20.0 million private placement with institutional investors.
• Alpha Pro Tech, Ltd. APT gained 22.4% to close at $7.15.
• Cue Health Inc. HLTH climbed 21.9% to close at $15.66. Cue Health recently announced partnership with Air Canada to provide US-based passengers with access to its molecular COVID-19 test.
• Tarena International, Inc. TEDU shares rose 19.1% to settle at $1.75.
• Nxt-ID, Inc. NXTD gained 17.7% to close at $4.72 after surging around 20% on Thursday.
• Identiv, Inc. INVE jumped 16% to close at $28.33. Identiv reported a partnership with TrueGreen to accelerate radio frequency ID-enabled smart packaging in cannabis market.
• MediaCo Holding Inc. MDIA gained 16% to settle at $4.78.
• Zhangmen Education Inc. ZME jumped 15.7% to close at $7.00.
• Theseus Pharmaceuticals, Inc. THRX surged 15.6% to close at $12.88.
• IceCure Medical Ltd ICCM gained 15.4% to close at $3.29. IceCure Medical, last week, received notice of intention to grant a European patent covering its cryogenic pump.
• Twin Vee Powercats Co. VEEE jumped 15.3% to close at $4.14.
• HTG Molecular Diagnostics, Inc. HTGM shares gained 15.3% to settle at $5.04. HTG recently completed HTP product next-phase development milestone.
• Optical Cable Corporation OCC gained 15.1% to settle at $5.58. Optical Cable recently posted Q4 sales of $15.88 million.
• Sino-Global Shipping America, Ltd. SINO rose 11.9% to close at $4.32.
• Rani Therapeutics Holdings, Inc. RANI climbed 11.2% to close at $20.69.
• CPI Aerostructures, Inc. CVU surged 9.2% to close at $2.49 after the company swung to a profit in the first quarter.
• GoDaddy Inc. GDDY gained 8.4% to settle at $82.35 following a media report stating that activist hedge fund Starboard Value has acquired a 6.5% stake in the company.
• Wejo Group Limited WEJO gained 8.2% to close at $7.09.
• Lucid Diagnostics Inc. LUCD rose 6.3% to close at $5.23. Ascendiant Capital initiated coverage on Lucid Diagnostics with a Buy rating and announced a price target of $16.
• Genocea Biosciences, Inc. GNCA shares rose 5.2% to close at $1.31 after gaining around 20% on Thursday.

Check out these big penny stock gainers and losers

Losers
 

• BridgeBio Pharma, Inc. BBIO shares tumbled 72% to close at $11.38 on Monday after the company's phase 3 trial to treat symptomatic transthyretin amyloid cardiomyopathy did not achieve its primary endpoint.
• Ensysce Biosciences, Inc. ENSC shares fell 20.3% to close at $4.08. Ensysce Biosciences recently said that the first patients have been enrolled in Phase 1 study of PF614-MPAR, its unique technology platform to provide opioid overdose protection.
• TRACON Pharmaceuticals, Inc. TCON fell 20.2% to close at $2.91. TRACON Pharma's Independent Data Monitoring Committee recommends the company continue its ENVASARC trial.
• Metacrine, Inc. MTCR dropped 20.2% to settle at $0.6630 after the company announced the resignation of the Chief Medical Officer.
• Applied UV, Inc. AUVI fell 17.3% to close at $4.11.
• Alnylam Pharmaceuticals, Inc. ALNY tumbled 17.1% to close at $161.11. The FDA recently approved Alnylam Pharmaceuticals’ Leqvio (inclisiran) to lower low-density lipoprotein cholesterol (LDL-C).
• Pluristem Therapeutics Inc. PSTI dipped 17% to settle at $1.61 after the company reported results from its Phase II studies of acute respiratory distress syndrome associated with COVID-19 did not meet the primary efficacy endpoint of statistically significant improvement of VFD at 28 days.
• Century Therapeutics, Inc. IPSC fell 17% to settle at $15.08.
• BiondVax Pharmaceuticals Ltd. BVXV dropped 16.2% to close at $2.33 after the company priced an offering of roughly 3.81 million ADSs at $2.36 per ADS.
• Mobiquity Technologies, Inc. MOBQ dipped 15.8% to settle at $2.19. Mobiquity Technologies recently announced new service offerings for MobiExchange, the Company’s SaaS platform for digital advertising and data services.
• MyMD Pharmaceuticals, Inc. MYMD dropped 15.7% to close at $5.70.
• PainReform Ltd. PRFX declined 14.4% to settle at $1.37. PainReform, last month, posted a net loss of $5.5 million during 9 months ended Sept. 30, 2021.
• Femasys Inc. FEMY fell 14.4% to close at $3.92. Femasys, last month, posted a Q3 loss of $0.19 per share.
• Aerie Pharmaceuticals, Inc. AERI dropped 14.2% to close at $7.31. Aerie Pharmaceuticals recently appointed Raj Kannan as Chief Executive Officer.
• Biofrontera Inc. BFRI fell 12.8% to close at $11.49.
• Society Pass Incorporated SOPA fell 12.1% to settle at $14.04 following approximately 400% gain in share price over the past week.
• InnovAge Holding Corp. INNV dropped 11.3% to close at $4.71 after the Centers for Medicare and Medicaid Services determined to suspend new enrollments at the company's Colorado centers based on deficiencies detected in an audit. The company withdrew FY22 guidance as a result.
• Novavax, Inc. NVAX fell 11% to close at $157.80. Novavax recently reported initial data evaluating the immune response of its COVID-19 vaccine, NVX-CoV2373, against the omicron variant as well as additional data from its ongoing Phase 2 boost study.
• Fathom Digital Manufacturing Corp. FATH fell 10.3% to close at $9.45.
• Pear Therapeutics, Inc. PEAR fell 9.9% to close at $5.09.
• Genfit SA GNFT fell 9.6% to close at $4.88. Genfit and Ipsen recently announced an exclusive licensing agreement for elafibranor.
• Pasithea Therapeutics Corp. KTTA fell 8.5% to close at $1.84 after jumping more than 36% on Thursday. Pasithea recently said it expanded its footprint with second Ketamine Therapy Clinic in the UK.
• iSpecimen Inc. ISPC fell 8.3% to close at $10.65.
• Taboola.com Ltd. TBLA dipped 8.1% to close at $7.41. Taboola.com recently launched a new native bidding service, allowing Taboola to extend its existing and growing 14,000 advertiser base to other supply types.